文献速递妇科产科

宫内节育器穿孔与脱落关联研究(APEX-IUD)的设计:多中心回顾性队列研究

Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2021-01-15

APEX-IUD 是由美国食品药品监督管理局要求开展的多中心回顾性队列研究,纳入 4 个医疗系统 326,658 名至少放置一次宫内节育器的女性,旨在评估哺乳期或产后 12 个月内放置与子宫穿孔及装置脱落的风险,并描述研究设计、方法、分析计划及人群特征。

要点

  • 研究纳入 326,658 名放置宫内节育器的女性,中位连续入组时间 90 个月。
  • 97,824 名女性在产后 ≤52 周内放置,其中 97% 明确了放置时哺乳状态。
  • 采用 Cox 回归和倾向评分重叠权重调整混杂,结局为子宫穿孔和装置脱落。

核心结论

  • 多中心回顾性数据整合可构建大样本、多样化研究人群,为宫内节育器穿孔和脱落风险提供真实世界证据。

研究设计与样本

  • APEX-IUD 为回顾性队列研究,在 4 个拥有电子健康记录的组织开展,纳入至少放置一次宫内节育器的女性共 326,658 名。
  • 暴露变量包括放置时哺乳、产后放置时机、装置类型及放置前一年月经过多诊断,协变量包括人口学、临床及手术相关变量。
  • 随访从放置开始,至结局发生、 censoring 事件或研究期结束(2018 年 6 月 30 日)。

主要发现

  • 研究人群平均年龄 32 岁,平均体重指数 28.5 kg/m2,10.0% 在放置前 ≤12 个月有月经过多,5.3% 有子宫肌瘤,10% 近期吸烟。
  • 79.4% 使用左炔诺孕酮释放装置,19.5% 使用铜装置。
  • 97,824 名女性在产后 ≤52 周内放置,其中 94,817 名(97%)确定了放置时哺乳状态;228,834 名在产后 >52 周或记录中无分娩证据时放置。

临床怎么用

  • 研究结果将为临床医生提供关于宫内节育器穿孔和脱落风险因素的真实世界证据,设计时与临床医生合作并验证结局以确保反映美国当前临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intrauterine devices are effective and safe, long-acting reversible contraceptives, but the risk of uterine perforation occurs with an estimated incidence of 1 to 2 per 1000 insertions. The European Active Surveillance Study for Intrauterine Devices, a European prospective observational study that enrolled 61,448 participants (2006-2012), found that women breastfeeding at the time of device insertion or with the device inserted at ≤36 weeks after delivery had a higher risk of uterine perforation. The Association of Uterine Perforation and Expulsion of Intrauterine Device (APEX-IUD) study was a Food and Drug Administration-mandated study designed to reflect current United States clinical practice. The aims of the APEX-IUD study were to evaluate the risk of intrauterine device-related uterine perforation and device expulsion among women who were breastfeeding or within 12 months after delivery at insertion. OBJECTIVE: We aimed to describe the APEX-IUD study design, methodology, and analytical plan and present population characteristics, size of risk factor groups, and duration of follow-up. STUDY DESIGN: APEX-IUD study was a retrospective cohort study conducted in 4 organizations with access to electronic health records: Kaiser Permanente Northern California, Kaiser Permanente Southern California, Kaiser Permanente Washington, and Regenstrief Institute in Indiana. Variables were identified through structured data (eg, diagnostic, procedural, medication codes) and unstructured data (eg, clinical notes) via natural language processing. Outcomes include uterine perforation and device expulsion; potential risk factors were breastfeeding at insertion, postpartum timing of insertion, device type, and menorrhagia diagnosis in the year before insertion. Covariates include demographic characteristics, clinical characteristics, and procedure-related variables, such as difficult insertion. The first potential date of inclusion for eligible women varies by research site (from January 1, 2001 to January 1, 2010). Follow-up begins at insertion and ends at first occurrence of an outcome of interest, a censoring event (device removal or reinsertion, pregnancy, hysterectomy, sterilization, device expiration, death, disenrollment, last clinical encounter), or end of the study period (June 30, 2018). Comparisons of levels of exposure variables were made using Cox regression models with confounding adjusted by propensity score weighting using overlap weights. RESULTS: The study population includes 326,658 women with at least 1 device insertion during the study period (Kaiser Permanente Northern California, 161,442; Kaiser Permanente Southern California, 123,214; Kaiser Permanente Washington, 20,526; Regenstrief Institute, 21,476). The median duration of continuous enrollment was 90 (site medians 74-177) months. The mean age was 32 years, and the population was racially and ethnically diverse across the 4 sites. The mean body mass index was 28.5 kg/m2, and of the women included in the study, 10.0% had menorrhagia ≤12 months before insertion, 5.3% had uterine fibroids, and 10% were recent smokers; furthermore, among these women, 79.4% had levonorgestrel-releasing devices, and 19.5% had copper devices. Across sites, 97,824 women had an intrauterine device insertion at ≤52 weeks after delivery, of which 94,817 women (97%) had breastfeeding status at insertion determined; in addition, 228,834 women had intrauterine device insertion at >52 weeks after delivery or no evidence of a delivery in their health record. CONCLUSION: Combining retrospective data from multiple sites allowed for a large and diverse study population. Collaboration with clinicians in the study design and validation of outcomes ensured that the APEX-IUD study results reflect current United States clinical practice. Results from this study will provide valuable information based on real-world evidence about risk factors for intrauterine devices perforation and expulsion for clinicians.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Anthony MS, Reed SD, Armstrong MA, et al. Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study. Am J Obstet Gynecol. 2021. PMID: 33460585. doi:10.1016/j.ajog.2021.01.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。